Target intelligence / Profile preview

Oral biofilm matrix protein

Molecular classification
Other
01

Overview

Oral biofilm matrix proteins are a diverse set of bacterial and host-derived proteins embedded within the extracellular polymeric substances matrix of microbial biofilms found in the oral cavity. They play critical roles in adhesion, structural integrity, enzymatic activity, metabolic support, antimicrobial resistance, and modulation of host immune responses. Key classes include surface adhesins (pili, fimbriae), amyloid-like fibers (curli, antigen I/II, WapA), leucine-rich repeat proteins, stress-response proteins, and exoenzymes. These proteins, along with exopolysaccharides, eDNA, and lipids, form a resilient matrix that underlies the architecture and pathogenesis of oral biofilms. Interventions targeting matrix proteins aim to disrupt biofilm formation, destabilize mature biofilms, and enhance antimicrobial efficacy, addressing chronic oral diseases such as caries and periodontitis. However, the term connotes a broad and heterogeneous class rather than a single actionable target for drug discovery.

Other names
Dental plaque matrix proteinBiofilm EPS proteinExtracellular polymeric substance proteinOral plaque biofilm protein
02

Mechanism of action

Disruption of protein-mediated adhesion; Enzymatic degradation of matrix scaffold; Alteration of protein folding and aggregation; Blockade of amyloid formation; Enhancement of immune clearance

03

Biological functions

Structural integrityAdhesionEnzymatic activityNutrient processingImmune evasionAntimicrobial resistance
04

Disease associations

InfectionInflammationDental cariesPeriodontal disease
05

Safety considerations

Off-target effects on host proteinsInduction of antimicrobial resistanceDisruption of oral microbiome balanceMucosal irritation or toxicity (from enzymatic or biocidal agents)
06

Interacting drugs

Chlorhexidine

4 more in the full profile.

07

Biomarkers

Amyloid-like protein content (from *S. mutans*)Surface adhesin levels (e.g., antigen I/II, leucine-rich repeat proteins)eDNA-protein complexes (for early biofilm formation)

Beyond the preview

Go deeper on Oral biofilm matrix protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oral biofilm matrix protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call